4th Quarter - Amendment

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$2,390,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 17, 2025 $2,710,000 Replaced
4th Quarter - Amendment Jan 21, 2025 $2,760,000 Replaced
4th Quarter - Amendment Feb 14, 2025 $2,830,000 Replaced
4th Quarter - Amendment (this page) Mar 20, 2025 $2,390,000 Replaced
4th Quarter - Amendment Mar 21, 2025 $1,600,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Appropriations

LobbyistCovered position, as disclosed
PAULA BURG —

Contacted: SENATE

Health Issues HCR

Inflation Reduction Act (IRA) HR 7174 - Ensuring Pathways to Innovative Cures (EPIC) Act Medicare Price Setting Drug Shortages Global Access to Medicines Trade-Related Aspects of Intellectual Property Rights (IPR) March-in Framework Guidance and Policies S 79/ HR 1717 - Interagency Patent Coordination and Improvement Act of 2023 S 142 - Preserve Access to Affordable Generics and Biosimilars Act HR 6986 - To address patent thickets S 150 - Affordable Prescriptions for Patients Act of 2023 S 2780/ HR 5429 - Medication Affordability and Patent Integrity Act Antimicrobial Resistance PBM Transparency and Reform S 1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S 3430 - Better Mental Health Care, Lower-Cost Drugs and Extenders Act S 2973 - Modernizing and Ensuring PMB Accountability Act 340B Reform HR 8574 - 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 8574 (118th), H.R. 1717 (118th), H.R. 7174 (118th), H.R. 5429 (118th), H.R. 6986 (118th)

Medicare/Medicaid MMM

S 723/HR 1458 - Access to Prescription Digital Therapeutics Act HR 8816 - American Medical Innovation and Investment Act of 2024

LobbyistCovered position, as disclosed
PAULA BURG —
FRANCISCO CARRILLO —
MATTHEW STROIA —
ANGELA BOOTHE WILES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8816 (118th), H.R. 1458 (118th)

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act (TCJA) VICP Reform and Excise Tax Vaccine Injury Compensation Fund VICP Transition Comprehensive Federal Tax Reform

LobbyistCovered position, as disclosed
PAULA BURG —
EMILY MUELLER —
MATTHEW STROIA —
JENNIFER SWENSON WALTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

International Supply Chain HR 4307/S 2115 - Medical Supply Chain Resiliency Act

LobbyistCovered position, as disclosed
ELISSA ALBEN —
STEPHEN CLAEYS —
MATTHEW STROIA —

Contacted: White House Office; U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4307 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.